Ajay Nirula
Impact in
- Immunology top 2%
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
- Dermatology top 1%
- Dermatology and Skin Diseases
Papers in
- Immunology 25
- Psoriasis: Treatment and Pathogenesis 13
- T-cell and B-cell Immunology 4
-
- SARS-CoV-2 and COVID-19 Research 8
- COVID-19 Clinical Research Studies 6
- Co-authors
- Paul Klekotka (15 shared papers)Scott Glaser (1 shared paper)Susan L. Kalled (1 shared paper)Greg Kricorian (5 shared papers)Alan R. Shuldiner (3 shared papers)Kim Papp (4 shared papers)Jesse Roth (3 shared papers)Maria Greenwald (6 shared papers)
- Journals
- Annals of the Rheumatic Diseases (7 papers)Journal of the American Academy of Dermatology (4 papers)New England Journal of Medicine (2 papers)Journal of Allergy and Clinical Immunology (2 papers)The Journal of Clinical Pharmacology (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Ajay Nirula
51 papers receiving 2.2k citations
Ajay Nirula's Hit Papers
Peers
Comparison fields: 5 of 105
- Immunology 1.2k
- Dermatology 336
- Rheumatology 473
- Hematology 162
- Infectious Diseases 179
Countries citing papers authored by Ajay Nirula
This map shows the geographic impact of Ajay Nirula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajay Nirula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajay Nirula more than expected).
Fields of papers citing papers by Ajay Nirula
This network shows the impact of papers produced by Ajay Nirula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajay Nirula. The network helps show where Ajay Nirula may publish in the future.
Co-authors
The 25 scholars most cited alongside Ajay Nirula, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 388 | |
| 2 | 2014 | 320 | |
| 3 | 2010 | 236 | |
| 4 | 2020 | 109 | |
| 5 | 2014 | 99 | |
| 6 | 2016 | 97 | |
| 7 | 1989 | 86 | |
| 8 | A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis Hit paper breakdown → | 2023 | 83 |
| 9 | 2015 | 59 | |
| 10 | 2004 | 56 | |
| 11 | 2014 | 48 | |
| 12 | 2019 | 47 | |
| 13 | 2016 | 42 | |
| 14 | 2018 | 40 | |
| 15 | 1992 | 38 | |
| 16 | 2014 | 37 | |
| 17 | 2006 | 37 | |
| 18 | 1992 | 35 | |
| 19 | 1997 | 32 | |
| 20 | 1990 | 31 |
About Ajay Nirula
Ajay Nirula is a scholar working on Immunology, Infectious Diseases, Rheumatology, Molecular Biology and Physiology, having authored 52 papers that have together received 2.2k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (13 papers), SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (6 papers), Asthma and respiratory diseases (5 papers), T-cell and B-cell Immunology (4 papers), Dermatology and Skin Diseases (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). The work is most often cited by research in Immunology (1.2k citations), Dermatology (336 citations), Rheumatology (473 citations), Hematology (162 citations) and Infectious Diseases (179 citations). Ajay Nirula has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Paul Klekotka, Scott Glaser, Susan L. Kalled, Greg Kricorian, Alan R. Shuldiner, Kim Papp, Jesse Roth, Maria Greenwald, Ngozi Erondu and Mark C. Genovese. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology, New England Journal of Medicine, Journal of Allergy and Clinical Immunology and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.